Edition:
United States

Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

64.51USD
10:59am EST
Change (% chg)

$-0.51 (-0.78%)
Prev Close
$65.02
Open
$64.99
Day's High
$65.32
Day's Low
$64.48
Volume
150,828
Avg. Vol
849,846
52-wk High
$78.36
52-wk Low
$61.06

Chart for

About

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $35,100.02
Shares Outstanding(Mil.): 532.14
Dividend: 0.19
Yield (%): 1.15

Financials

  BAX.N Industry Sector
P/E (TTM): 20.02 30.69 30.88
EPS (TTM): 3.29 -- --
ROI: 12.39 12.93 13.80
ROE: 19.36 15.64 15.29

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc said on Thursday talks with U.S.-based ICU Medical Inc over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

Sep 13 2018

UPDATE 1-Smiths Group, ICU Medical close to abandoning healthcare merger -Sky News

Aug 7 British engineering firm Smiths Group Plc is close to abandoning talks with U.S.-based ICU Medical Inc over a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

Aug 07 2018

Earnings vs. Estimates